Drug Type Nanobody, Therapeutic radiopharmaceuticals |
Synonyms Lu177-RAD206, RAD 206, RAD206 |
Target |
Action inhibitors |
Mechanism Trop-2 inhibitors(Tumor-associated calcium signal transducer 2 inhibitors), Ionising radiation emitters |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Triple Negative Breast Cancer | Preclinical | Australia | - | |
Non-Small Cell Lung Cancer | Discovery | - | 03 Jan 2024 |